2403 SIDNEY STREET, PITTSBURGH, PA
Market cap: $80.9M (2/10/2026)
Price: $1.10
Completes Type C Meeting with FDA for Zervimesine (CT1812) in Dementia with Lewy Bodies
Material disclosure
Reports Financial Results for the Third Quarter 2025 and Highlights Progress Across Clinical Programs
Investor Presentation
News, Underwriting Agreement, Securities Holder Rights or Indentures, Legal Opinion, Material Contracts
Other Events
Reports Financial Results for the Second Quarter 2025 and Highlights Progress Across Clinical Programs
Shareholder votes
Q3
Q2
Q1
FY 2024
FY 2023
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload